XORTX Therapeutics Inc. - ROE
XRTX
Price:
$2.09
Market Cap:
$595.66K
XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to advancing and bringing to market medical treatments targeting a range of conditions, including chronic kidney ailments, diabetes, insulin resistance, metabolic syndrome, diabetic nephropathy, and various infections. Their pipeline includes XRx-008, a late-stage clinical program designed to address autosomal dominant polycystic kidney disease (ADPKD). Another key candidate is XRx-101, an agent aimed at reducing uric acid levels in COVID-19 patients, with the goal of mitigating acute kidney injury and related complications. Furthermore, they are developing XRx-221, a series of xanthine oxidase inhibitors intended for the manageme...[Read more]
Industry
Biotechnology
IPO Date
2021-09-23
Stock Exchange
NASDAQ
Ticker
XRTX
PE Ratio
[-0.85]
ROE
[-135.33%]
Current Ratio
[0.43]
Dividend Yield
[0%]
Enterprise Value
[360.28K]
Dividend History
The ROE as of June 2026 (TTM) for XORTX Therapeutics Inc. (XRTX) is -135.33%
According to XORTX Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -135.33%. This represents a change of 262.22% compared to the average of -37.36% of the last 4 quarters.
XORTX Therapeutics Inc. (XRTX) Historical ROE (quarterly & annually)
How has XRTX ROE performed in the past?
The mean historical ROE of XORTX Therapeutics Inc. over the last ten years is -117.44%. The current -135.33% ROE has changed 15.23% with respect to the historical average. Over the past ten years (40 quarters), XRTX's ROE was at its highest in in the September 2021 quarter at 197.09%. The ROE was at its lowest in in the June 2019 quarter at -753.44%.
Average
-117.44%
Median
-78.10%
Minimum
-1174.33%
Maximum
297.36%
XORTX Therapeutics Inc. (XRTX) ROE by Quarter and Year
Discovering the peaks and valleys of XORTX Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 698.15%
Maximum Annual ROE = 297.36%
Minimum Annual Increase = -1721.16%
Minimum Annual ROE = -1174.33%
| Year | ROE | Change |
|---|---|---|
| 2025 | -129.90% | 37.33% |
| 2024 | -94.59% | 53.57% |
| 2023 | -61.60% | -38.33% |
| 2022 | -99.89% | 698.15% |
| 2021 | -12.51% | -87.76% |
| 2020 | -102.26% | -134.39% |
| 2019 | 297.36% | -125.32% |
| 2018 | -1174.33% | -1721.16% |
| 2017 | 72.44% | -44.64% |
| 2016 | 130.84% | -192.41% |
XORTX Therapeutics Inc. (XRTX) Average ROE
How has XRTX ROE performed in the past?
The current ROE of XORTX Therapeutics Inc. (XRTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-95.36%
5-year avg
-79.70%
10-year avg
-117.44%
XORTX Therapeutics Inc. (XRTX) ROE vs. Peers
How is XRTX’s ROE compared to its peers?
XORTX Therapeutics Inc.’s ROE is greater than NewcelX Ltd. (-100.99%), greater than Windtree Therapeutics, Inc. (-1302.82%), greater than Virax Biolabs Group Limited (-102.54%), less than NKGen Biotech, Inc. Common Stock (55.88%), greater than Dermata Therapeutics, Inc. (-127.91%), greater than PMGC Holdings Inc. (-116.96%), greater than Avenue Therapeutics, Inc. (-65.83%), less than Moolec Science S.A. (376.84%), greater than GT Biopharma, Inc. (-901.32%), greater than Lexaria Bioscience Corp. (-190.06%),
| Company | ROE | Market cap |
|---|---|---|
| -100.99% | $1.49M | |
| -1302.82% | $674.18K | |
| -102.54% | $751.16K | |
| 55.88% | $7.84M | |
| -127.91% | $797.42K | |
| -116.96% | $2.69M | |
| -65.83% | $1.07M | |
| 376.84% | $5.94M | |
| -901.32% | $5.46M | |
| -190.06% | $11.04M |
Build a custom stock screener for XORTX Therapeutics Inc. (XRTX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XORTX Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
XORTX Therapeutics Inc. (XRTX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like XORTX Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is XORTX Therapeutics Inc.'s ROE?
How is the ROE calculated for XORTX Therapeutics Inc. (XRTX)?
What is the highest ROE for XORTX Therapeutics Inc. (XRTX)?
What is the 3-year average ROE for XORTX Therapeutics Inc. (XRTX)?
What is the 5-year average ROE for XORTX Therapeutics Inc. (XRTX)?
How does the current ROE for XORTX Therapeutics Inc. (XRTX) compare to its historical average?